BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

545 related articles for article (PubMed ID: 19297572)

  • 21. HCMV glycoprotein B subunit vaccine efficacy mediated by nonneutralizing antibody effector functions.
    Nelson CS; Huffman T; Jenks JA; Cisneros de la Rosa E; Xie G; Vandergrift N; Pass RF; Pollara J; Permar SR
    Proc Natl Acad Sci U S A; 2018 Jun; 115(24):6267-6272. PubMed ID: 29712861
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel therapeutic cytomegalovirus DNA vaccine in allogeneic haemopoietic stem-cell transplantation: a randomised, double-blind, placebo-controlled, phase 2 trial.
    Kharfan-Dabaja MA; Boeckh M; Wilck MB; Langston AA; Chu AH; Wloch MK; Guterwill DF; Smith LR; Rolland AP; Kenney RT
    Lancet Infect Dis; 2012 Apr; 12(4):290-9. PubMed ID: 22237175
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytomegalovirus (CMV) glycoprotein H-based serological analysis in Japanese healthy pregnant women, and in neonates with congenital CMV infection and their mothers.
    Ikuta K; Minematsu T; Inoue N; Kubo T; Asano K; Ishibashi K; Imamura T; Nakai H; Yoshikawa T; Moriuchi H; Fujiwara S; Koyano S; Suzutani T
    J Clin Virol; 2013 Oct; 58(2):474-8. PubMed ID: 23916379
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic mechanism associated with congenital cytomegalovirus infection and analysis of effects of the infection on pregnancy outcome.
    Li JM; Zhang HF; Zhang XQ; Huang GL; Huang HZ; Yu WW
    Genet Mol Res; 2015 Oct; 14(4):13247-57. PubMed ID: 26535638
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of cytomegalovirus infection during clinical trials of glycoprotein B vaccine.
    Zhang C; Pass RF
    Vaccine; 2004 Dec; 23(4):507-10. PubMed ID: 15530699
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Replication-Defective Human Cytomegalovirus Vaccine Elicits Humoral Immune Responses Analogous to Those with Natural Infection.
    Liu Y; Freed DC; Li L; Tang A; Li F; Murray EM; Adler SP; McVoy MA; Rupp RE; Barrett D; Ye X; Zhang N; Beck K; Culp T; Das R; Song L; Vora K; Zhu H; Wang D; Espeseth AS; An Z; Musey L; Fu TM
    J Virol; 2019 Dec; 93(23):. PubMed ID: 31511385
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An enveloped virus-like particle alum-adjuvanted cytomegalovirus vaccine is safe and immunogenic: A first-in-humans Canadian Immunization Research Network (CIRN) study.
    Langley JM; Gantt S; Halperin SA; Ward B; McNeil S; Ye L; Cai Y; Smith B; Anderson DE; Mitoma FD
    Vaccine; 2024 Jan; 42(3):713-722. PubMed ID: 38142214
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Humoral Immune Correlates for Prevention of Postnatal Cytomegalovirus Acquisition.
    Saccoccio FM; Jenks JA; Itell HL; Li SH; Berry M; Pollara J; Casper C; Gantt S; Permar SR
    J Infect Dis; 2019 Jul; 220(5):772-780. PubMed ID: 31107951
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety and immunogenicity of Towne cytomegalovirus vaccine with or without adjuvant recombinant interleukin-12.
    Jacobson MA; Sinclair E; Bredt B; Agrillo L; Black D; Epling CL; Carvidi A; Ho T; Bains R; Girling V; Adler SP
    Vaccine; 2006 Jun; 24(25):5311-9. PubMed ID: 16701925
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibody binding to native cytomegalovirus glycoprotein B predicts efficacy of the gB/MF59 vaccine in humans.
    Jenks JA; Nelson CS; Roark HK; Goodwin ML; Pass RF; Bernstein DI; Walter EB; Edwards KM; Wang D; Fu TM; An Z; Chan C; Permar SR
    Sci Transl Med; 2020 Nov; 12(568):. PubMed ID: 33148624
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Trial of Hyperimmune Globulin to Prevent Congenital Cytomegalovirus Infection.
    Hughes BL; Clifton RG; Rouse DJ; Saade GR; Dinsmoor MJ; Reddy UM; Pass R; Allard D; Mallett G; Fette LM; Gyamfi-Bannerman C; Varner MW; Goodnight WH; Tita ATN; Costantine MM; Swamy GK; Gibbs RS; Chien EK; Chauhan SP; El-Sayed YY; Casey BM; Parry S; Simhan HN; Napolitano PG; Macones GA;
    N Engl J Med; 2021 Jul; 385(5):436-444. PubMed ID: 34320288
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Maternal immunity and prevention of congenital cytomegalovirus infection.
    Fowler KB; Stagno S; Pass RF
    JAMA; 2003 Feb; 289(8):1008-11. PubMed ID: 12597753
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An attenuated cytomegalovirus vaccine with a deletion of a viral chemokine gene is protective against congenital CMV transmission in a guinea pig model.
    Leviton MP; Lacayo JC; Choi KY; Hernandez-Alvarado N; Wey A; Schleiss MR
    Clin Dev Immunol; 2013; 2013():906948. PubMed ID: 24000289
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vaccination of seropositive subjects with CHIRON CMV gB subunit vaccine combined with MF59 adjuvant for production of CMV immune globulin.
    Drulak MW; Malinoski FJ; Fuller SA; Stewart SS; Hoskin S; Duliege AM; Sekulovich R; Burke R; Winston S
    Viral Immunol; 2000; 13(1):49-56. PubMed ID: 10733168
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Progress on human cytomegalovirus vaccines for prevention of congenital infection and disease.
    Wang D; Fu TM
    Curr Opin Virol; 2014 Jun; 6():13-23. PubMed ID: 24632198
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunization to prevent congenital cytomegalovirus infection.
    Adler SP
    Br Med Bull; 2013; 107():57-68. PubMed ID: 23954939
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytomegalovirus vaccines.
    McVoy MA
    Clin Infect Dis; 2013 Dec; 57 Suppl 4(Suppl 4):S196-9. PubMed ID: 24257427
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epitope-Specific Humoral Responses to Human Cytomegalovirus Glycoprotein-B Vaccine With MF59: Anti-AD2 Levels Correlate With Protection From Viremia.
    Baraniak I; Kropff B; McLean GR; Pichon S; Piras-Douce F; Milne RSB; Smith C; Mach M; Griffiths PD; Reeves MB
    J Infect Dis; 2018 May; 217(12):1907-1917. PubMed ID: 29528415
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glycoprotein B vaccine is capable of boosting both antibody and CD4 T-cell responses to cytomegalovirus in chronically infected women.
    Sabbaj S; Pass RF; Goepfert PA; Pichon S
    J Infect Dis; 2011 Jun; 203(11):1534-41. PubMed ID: 21592981
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety and immunogenicity of a bivalent cytomegalovirus DNA vaccine in healthy adult subjects.
    Wloch MK; Smith LR; Boutsaboualoy S; Reyes L; Han C; Kehler J; Smith HD; Selk L; Nakamura R; Brown JM; Marbury T; Wald A; Rolland A; Kaslow D; Evans T; Boeckh M
    J Infect Dis; 2008 Jun; 197(12):1634-42. PubMed ID: 18444883
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.